Highly rated in
Highly rated in
Check Ki H. Lee's experience treating your condition:
About Ki H. Lee

Ki Lee practices in Cheongju, Republic of Korea. Lee is highly rated in 9 conditions, according to our data. Their top areas of expertise are Paronychia, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NCSLC), Lung Cancer, and Bone Marrow Aspiration.

Their clinical research consists of co-authoring 115 peer reviewed articles and participating in 13 clinical trials in the past 15 years.

Cheongju, KR
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

An Open-Label, Multicenter, Phase 2 Study of the Safety and Efficacy of KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer (SCLC)
A Randomized Phase 3 Multicenter Open-Label Study to Compare the Efficacy of TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
A Multicenter, Randomized, Double-Blind Study of Erlotinib in Combination With Ramucirumab or Placebo in Previously Untreated Patients With EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer
View 10 Less Clinical Trials -

Save this expert for later
Sign Up
Looking for the best expert for you?
Start Here
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more